The advent of new technologies and high-throughput sequencing enabled genome mapping of iCCA patients, leading to the identification of a clear molecular iCCA subtype harboring IDH1 mutations, with distinctive biological features. This evidence concerns the gene IDH1 and infantile convulsions and choreoathetosis.